The antibacterial activity of photodynamic agents against multidrug resistant bacteria causing wound infection.


Journal

Photodiagnosis and photodynamic therapy
ISSN: 1873-1597
Titre abrégé: Photodiagnosis Photodyn Ther
Pays: Netherlands
ID NLM: 101226123

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 07 06 2022
revised: 04 08 2022
accepted: 12 08 2022
pubmed: 24 8 2022
medline: 15 12 2022
entrez: 23 8 2022
Statut: ppublish

Résumé

Antimicrobial photodynamic inactivation (aPDI) of multidrug-resistant (MDR) wound pathogens was evaluated with cationic porphyrin derivatives (CPDs). MDR bacterial strains including Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii, and Klebsiella pneumoniae were used. The CPDs named PM, PE, PN, and PL were synthesized as a photosensitizer (PS). A diode laser with a wavelength of 655 nm was used as a light source. aPDI of the combinations formed with different energy densities (50, 100, and 150 J/cm²) and PS concentrations (ranging from 3.125 to 600 µM) were evaluated on each bacterial strain. Dark toxicity, cytotoxicity, and phototoxicity were determined on fibroblast cells. In the aPDI groups, survival reductions of up to 5.80 log₁₀ for E. coli, 5.90 log₁₀ for P. aeruginosa, 6.11 log₁₀ for K. pneumoniae, and 6.78 log₁₀ for A. baumannii were obtained. The cytotoxic effect of PL and PM on fibroblast cells was very limited. PN was the type of CPD with the highest dark toxicity on fibroblast cells. In terms of providing broad-spectrum aPDI without or with very limited cytotoxic effect, the best result was observed in aPDI application with PL. The other CPDs need some modifications to show bacterial selectivity for use at 50 µM and above.

Identifiants

pubmed: 35998880
pii: S1572-1000(22)00352-0
doi: 10.1016/j.pdpdt.2022.103066
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Photosensitizing Agents 0
Porphyrins 0
Anti-Infective Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103066

Informations de copyright

Copyright © 2022. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest No conflict of interest declared should appear within this section.

Auteurs

Ayşe Akbiyik (A)

Faculty of Health Sciences, Izmir Katip Çelebi University, Izmir Kâtip Çelebi Üniversitesi Balatçık Kampüsü, Çiğli, İzmir 35620, Turkey. Electronic address: ayse.akbiyik@ikc.edu.tr.

Hüseyin Taşli (H)

Faculty of Pharmacy, Department of Pharmaceutical Microbiology, Ege University, Turkey.

Nermin Topaloğlu (N)

Faculty of Engineering, Department of Biomedical Engineering, İzmir Katip Çelebi University, Turkey.

Vildan Alptüzün (V)

Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Ege University, Turkey.

Sülünay Parlar (S)

Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Ege University, Turkey.

Selçuk Kaya (S)

Faculty of Medicine, Department of Microbiology, İzmir Katip Çelebi University, Turkey. Electronic address: selcuk.kaya@ikc.edu.tr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH